Form 4: Director Steven Altman Transfers DexCom Shares to Trust

DexCom Director Steven R. Altman transferred 5,037 shares of common stock into his family trust.

Summary

• Director Steven R. Altman executed a transfer of 5,037 shares of DexCom common stock.
• The transaction involved moving shares from direct ownership to the Steven R. and Lisa J. Altman Family Trust.
• The transfer occurred on May 8, 2026, following the vesting of previously awarded restricted stock units.
• Following the transaction, the reporting person holds 63,667 shares indirectly through the trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative transfer of shares between personal accounts and a family trust.

Positives

• The transaction represents a change in ownership structure rather than a divestment, indicating continued long-term alignment with the company.

Negatives

• None.

Risks

• None.

Future Outlook

Not applicable as this is an ownership disclosure filing.

Industry Context

StockSavvy.ai notes that internal share transfers to family trusts are standard estate planning procedures for corporate directors and do not typically signal changes in sentiment regarding company performance.

Comparison to Industry Standards

• This transaction is consistent with standard corporate governance practices where directors consolidate holdings into family trusts for estate planning purposes.

Related Party Transactions

• Transfer of shares to the Steven R. and Lisa J. Altman Family Trust, where the reporting person serves as trustee.

Stakeholder Impact

• No material impact on shareholders or company operations.

Key Dates

Keywords

DexCom, DXCM, Insider Trading, Form 4, Director Ownership, Stock Transfer